May 16 2012
Join FOSEP on May 22nd in a seminar lead by Laura Wisland (Senior Energy Analyst for the Union of Concerned Scientists) and Chris Carney (Outreach Coordinator for UCS) focusing on “Lessons from California’s Adventures in Renewable Energy.
May 11 2012
Dr. Brian Baird addresses effective communication to Legislators
As the final seminar in the COSEE-Ocean Learning Communities (http://www.cosee.net) /Washington Sea Grant series “Beyond the Ivory Tower”, former Washington State Congressman Dr. Brian Baird was invited to speak about how scientists and their science is perceived by legislators and the necessity for clearly defining goals and the societal importance of your research in order to obtain state funding and support.
Dr. Baird is a licensed clinical psychologist and has a long history of commitment to science and education, and while a Congressman for Washington’s 3rd District sat on the Committee on Science and Technology where was a member of the Subcommittee on Research and Science Education and chaired the Subcommittee on Energy and Environment.
By outlining the severity of the US financial crisis, Dr. Baird began by showing several videos from well known Federal legislators who have taken dramatic steps to call scientific research into question, highlighting Representative Adrian Smith’s YouCut initiatives in which he asked his constituency to identify grants funded by NSF that they did not feel merited the spending of tax payer dollars.
Further, he emphasized that when interacting with politicians, there are three major ways that scientists communicate their ideas:
1. Written testimony, very comprehensive, often 10-15 pages long
2. Reading for committees in person, usually 5-10 minutes with a question and answer period.
3. The one minute “walk and talk” elevator speech. The key here is make your point quickly and give the politician a “leave behind”, a document or other item that either makes your point in a concise synthesis or an easy reminder.
By highlighting the difficulties legislators face when making funding decisions, Dr. Baird unscored the need for scientists to communicate with them. Among the most important points that scientists need to keep in mind
1. Ask yourself how important your research is. If money earmarked for a cause that everyone supports, such as breast cancer research, is your research as important as breast cancer research funding?
2. Determine a way to communicate with why your research is important. Use specific examples.
3. Legislation is a balancing act, and often your research can be absolutely crucial, however if a legislator cannot convince his/her constituency of this, they are at risk of losing their seat, even though empirical observations may support your work.
4. To prepare for communicating with legislators, you should find out as much as you can about the members of the subcommittee. Who is the chair? Who are the ranking members? Read the description of the purpose of the hearing very carefully. Establish friends ahead of time and offer intelligence that may allow them to better support your premise in light of adversity.
5. Scientists spend too much time talking to other people who understand their research. Put your information in language and that anyone can understand and prepare yourself by talking to others who do not have the same background.
The seminar culminated in four role play scenarios that actually happened while he was a member of the Washington Legislature, highlighting the differences between preconceived notions and how people can be persuaded by well constructed arguments.
Apr 11 2012
GPSS Science and Policy Summit Call for Abstracts!!!!
UW’s Graduate and Professional Student Senate (GPSS) is hosting the second annual Science and Policy Summit this coming May and are seeking abstract submissions for either a TED-style talk or poster presentation.
TED Talks – Presenter Abstracts
To kick off the 2nd Annual Science and Policy Summit the Graduate and Professional Student Senate (GPSS) will be hosting TED-style Talks on May 3rd, 2012 in the Burke Room at the Burke Museum. This event will be an opportunity for students and faculty to present their research in a short, concise way in order to encourage interest and dialogue about the interface of science and policy. A happy hour will follow this event. Any graduate or professional student or faculty members from the UW are welcome to attend and are encouraged to submit an abstract about a topic they wish to present on the results and policy implications of their research.
The best presentation will be voted on and a prize will be awarded at the end of the event. All presenters are expected to attend the entire event from 2:30-5pm on Thursday, May 3rd. Presentations should run from 8-10 minutes in length. Abstracts should summarize the content of the presentation material and be submitted by 12pm Friday April 13th, and the body of the abstract should not exceed 300 words. You will be notified by Friday April 20th regarding acceptance of your abstract.
Submit your abstracts here: https://catalyst.uw.edu/webq/
Poster Abstracts for the Science and Policy Summit
This year the Second Annual Science and Policy Summit will be accepting abstracts for poster presentations from across disciplines. Any graduate or professional student at the UW is welcome to submit an abstract about the results and policy implications of their research. This summit will be open to both students and community members, including researchers and policy makers. Last year posters ranged from disciplines including, but not limited to, those in the health sciences, medicine, environment, built environment, and urban planning.
Abstracts should summarize the proposed content of the material to be presented and submitted by 12pm Friday, April 13th. The body of the abstract should not exceed 300 words.
You will be notified by April 20th regarding acceptance of your abstract. The number of abstracts accepted is limited to the available space. Selected participants will be expected to set their posters up between 1pm-1:30pm on Tuesday, May 8thin the Walker Ames Room in Kane Hall and be available during the event to answer questions. Prize winners will be announced by FOSEP at the end of the summit at 5pm. Light refreshments will be provided.
You can submit your abstract here via catalyst: https://catalyst.uw.edu/webq/
If you have any questions about either of these events feel free to contact Kristen Hosey, GPSS Senator and Resource Assistant at gpssres@uw.edu
Mar 30 2012
ASBMB Hill Day was March 28th
This past week I traveled to Washington D.C. as part of ASBMB’s Hill Day. ASBMB (American Society of Biochemistry and Molecular Biology) is a nonprofit organization of basic biomedical science researchers with over 12,000 members. ASBMB publishes scientific and educational journals, organizes conferences, and advocates for science and educational funding. Since 1985 ASBMB has included a public affairs program managed by the Public Affairs Advisory Committee (PAAC). Each year the PAAC sponsors a “Hill Day.” Students, postdoctoral fellows, and PAAC members convene in Washington D.C. to learn about science policy and meet with their congressional representatives to advocate for basic science research funding.
This year’s Hill Day began on Monday night with a meet and greet followed by a “policy 101” training session. During the training session we first learned about what to do and not to do when meeting with a public official. Do bring leave behind materials and business cards, keep it short, arrive early, and be prepared to give a brief non-technical description of your research. Don’t patronize or complain, suggests programs that can be cut in order to increase your program of interest’s funding, and avoid partisanship. We next were given a short presentation regarding the current state of NIH funding. We learned that although NIH has received essentially flat funding for the past decade, when adjusted for inflation NIH has been cut by 18% since the end of the NIH doubling in 2003. Finally we learned about the major science related legislation going through congress such as the STAPLE Act, the Life Sciences Jobs and Investment Act of 2011, and the GAPCSA Act (note ASBMB supports the first two acts and opposes the third).
On Tuesday morning we traveled to D.C. for Hill Day. For this we were all split into small groups. My group consisted of 2 PAAC members, 1 postdoc, and 2 students and were from California, Washington, Montana, and Minnesota. Throughout the day we met with congressional staffers from each of these states. From Washington we spoke with staffers for Representative McDermott (7th district), Senator Cantwell, Senator Murray, and Representative Herrera Beutler (3rd district). Each meeting started with a short description of ASBMB and introductions by each member of the group. We then explained our ‘ask,’ an increase in NIH funding for FY2013 from 30.6 billion to 32.0 billion. This increase represents a 4.5% increase over FY2012 and accounts for inflation and a modest 1% growth. We also advocated for a future of predictable growth by asking for an increase in NIH funding by FY2015 to 35 billion. The majority of the offices we met with were very supportive of basic biomedical research and were proponents of increased NIH funding for FY2013, while a few offices told us just to be happy the NIH budget has not been getting cut. The day ended with a reception in the Russell Senate Building and the presentation of the Public Service Award.
Overall I very much enjoyed my trip to D.C. as part of ASBMB’s Hill Day. Being on Capitol Hill and meeting with congressional staffers was very exciting. I also learned a lot about the funding problems NIH is facing and about current major science policy issues. I highly recommend people interested in science outreach and advocacy to apply for ASBMB’s Hill Day in 2013.
Feb 21 2012
AAAS Annual Conference: Saturday
Exploding Myths on Reactor Security, Harm Reduction, and Genetically Modified Organisms
Day 2 started off with a very interesting although potentially one-sided panel aiming to dispel common misconceptions concerning three major global science policy issues. The first talk was given by Dr. Roland Schenkel, a nuclear energy consultant from Germany. The main theme of his talk was that keeping nuclear energy is imperative to a successful global future. His reasoning behind this was that nuclear energy is sustainable, it addresses climate change issues, and will secure long-term energy supply and thus reduce global tensions pertaining to gas availability. Additionally, he claimed that a new generation of safer and more efficient reactors are ready for deployment and solutions for waste disposal management are already available. Dr. Schenkel explained that although there are 30 countries with nuclear reactors, the regulations and policies involved varies substantially. He stressed that there needs to be pressure to establish a global regulatory framework for safety with internal benchmarks and that all work pertaining to nuclear energy needs to be open and transparent in order to increase public acceptance and dispel common misconceptions. The second talk was given by David Oriely, the Group Scientific Director for British America Tobacco. The main point of his presentation was that smoking harm reduction can be obtained by producing and marketing safer sources of nicotine. He presented data showing that people who use solely nicotine products such as snus or smokeless tobacco have an extremely decreased incidence of lung and other cancers. While I admit the data demonstrating that nicotine alone products are safer was convincing, the issue still exists that people will be ingesting nicotine, which will still hijack your brain reward pathways and produce adverse effects such as cross sensitization to other drugs of abuse. Dr. Guy van dee Eede from the Joint Research Center gave the final talk of the session which dealt with genetically modified organisms (GMOs). His main thesis was that GMOs are a revolution in evolution in that they are subject to evolution themselves and therefore should not be viewed as so foreign. He maintained that GMOs are an integral part of the future of global food supply and that work needs to be done to increase public knowledge and expel myths regarding GMOs. Overall I do agree with the myths presented and dispelled but I also would have liked to have heard from a similar panel presenting the opposing view on these controversial issues.
Carl Wieman, A Scientific Approach to Science Education
Dr. Carl Wieman is the Associate Director for Science in the Office of Science and Technology Policy within the Executive Office of the U.S. President and gave one of Saturday’s Topical Lectures. He described an alternative science teaching method to the typical teacher stand in front of a class and lecture from a textbook. He described that many teachers, including himself as a young professor, believe that when a student does not understand a seemingly basic concept it is because they are not trying hard enough and thus the answer is to teach them the same material again with that belief that eventually the student will get it. The new approach draws from the basis of how scientists think and then applies that to the classroom setting; scientists are experts that have a mental organizational framework that they can access and apply, they can see complex relationships and patterns, and have the ability to monitor their own thinking and learning process. The approach is to, instead of lecturing to a classroom about scientific concepts already explained in the assigned textbook, give the students challenging but doable tasks and questions with the explicit focus on expert-like thinking, feedback, and reflection. An example of this new method is to first pre-assign the textbook reading of the material and give a subsequent online quiz. Next, because the reading has already taken place, the class becomes about problem solving and critical thinking. Each student has a hand-held answer remote and the class begins with a multiple-choice question pertaining to the previously read material (data shows that when a student is forced to give an answer that they are accountable for they are more invested in the answer and think more deeply). Before the answer to the question is shown, small groups of students debate the various multiple-choice answers, then the class as a whole discusses the different answers, and finally the answer is shown and the problem is explained by the teacher. Dr. Weiman gave numerous examples of improved class performance using this new teaching strategy. An example taken from an introductory UW biology class showed that not only did some of the students improve with this teaching method but that the whole bell curve shifted to the right (including low performing and underrepresented or minority populations). Based on this very convincing real world data one would think that teachers around the world are accepting and using this new strategy, but in reality change has been hard to bring about. Dr. Weiman concluded his talk with speculation about why it has been so hard for teachers to give up the traditional methods but also with hope that with new efforts by organizations such as AAU, APLU, professional societies, and NAS, increasing numbers will begin to adopt these new strategies.
Beyond Evolution: Religious Questions in Science Classrooms
I was very excited to attend the session on religion and science, as I have on many occasions had to address these issues with friends and family. The talks focused on teaching evolution and climate change to religious students. Dr. Ken Miller from Brown University showed data demonstrating that as the level of education increases, even throughout the four years of college, the acceptance of evolution increases, regardless of religious view or political beliefs. Additionally data shows that as education level increases students stop believing in the idea that science and religion have to be in conflict and that either one or the other is correct. Surprisingly, while this increased belief in evolution is progressing, students in the sciences are also becoming more, not less religious! Unfortunately many students and the general public are shown anti-evolution propaganda and taught that science is evil and will destroy morality. Examples of Rick Santorum’s stance on science and evolution and documentaries like Expelled narrated by Ben Stein were given. Dr. Miller closed with a three-part strategy: one to teach more science, two to teach science as a process and not as a doctrine, and three to teach the interconnectedness of science and religion. His bottom line was that instead of adhering to the conflict model and pitting science against religion we should be teaching more and better science. Dr. Mark Mecafery next discussed the issues of teaching climate change to religious students. His talk focused on the history of climate change research, started in the early 1800s by contemporaries of Darwin. Studies done in the 1950s postulated that by year 2000 temperatures would be increasing and melting of the polar ice cap would be seen. Dr. Mecafery suggested that so many people deny that climate change is occurring because certain groups have made the environment and climate change into a new religion, again pitting science against religion and teaching an either/or belief. As far as solutions go, he also echoed Dr. Miller that we need to teach more, better science in an attempt to expel the now common notion that science is anti-religion and thus threatening to the sanctity of life.
Plenary Panel Science is not Enough
I ended the day with attending the Plenary Panel Science is not Enough. The panel was moderated by Dr. Frank Sesno and included Dr. James Hansen, Dr. Olivia Judson, and Dr. Hans Rosling. The panel addressed why even in the face of overwhelming data and support for climate change by the scientific community so much of the American public is in disbelief, and focused on the increasing need for outreach and communication by scientists. The panel was videotaped and will be available online, so instead of describing it, I will provide a link to the video when made available to the public.
Feb 20 2012
ASBMB: HILL DAY – a sponsored “policy 101″ training’s session in D.C.
Are you a young, motivated, curious scientist interested in science advocacy?
ASBMB sponsors an annual short trip aka “Hill Day” (very short, but fully-funded) to DC for students/postdocs across the country. There you will get exposed to a brief policy training’s session followed by meetings with congressional offices. The deadline is in 4 days (2/24) but the application is super short:
http://www.asbmb.org/Advocacy/advocacy.aspx?id=13812.
I heard great things about it, but haven’t gone myself. Go, come back and tell us about it!
Feb 19 2012
Optimism about renewable energy
A panel of energy experts expressed optimism that renewable sources can contribute to 50% of electricity production in the next 25 years. At the AAAS annual meeting in Vancouver, the session on a smarter electricity grid discussed both policy and technological challenges of improving delivery of power.
The panel focused on the technical challenges of reducing wasted electricity and anticipating future needs. However there appeared to be a consensus that the while the technological challenges were difficult, the policy would be the main driver in improving the grid and transitioning to renewable energy. If there is not a public and political will for cleaner and more efficient energy sources, there will be a continued reliance on fossil fuels, which are currently the cheapest source of power.
Feb 17 2012
AAAS Annual Conference: Friday
Secrets of a Science Communicator: Engaging General Audiences
First on my agenda today was a Career Development Workshop held by Andy Torr, Communications & Research Resource Officer at the University of British Columbia. Throughout the session Torr repeatedly stressed that successful science communication is not about knowing your audience or crafting a simple key message, but instead about telling a story, sharing an experience, and engaging your audience in order to obtain leverage and create a ripple effect. He split his talk into three acts. Act 1 dealt with You. Torr described a triangle in which ethos (credibility) was at the top corner and logos (logic) and pathos (human-ness) are at the bottom corners. He explained that if you lean too far towards one bottom corner, logos or pathos, you lose ethos and thus lose your credibility and your audience. He also gave the example of Simon Sinek’s Golden Circle (a series of concentric circles with why in the inner most circle, then how in the middle circle, and what in the outer circle). Torr explained that while most people communicate from the outside in, the best leaders communicate from the inside out. Act 2 dealt with Them. He explained that people normally retrieve what we believe and that everyone has different experiences and therefore different beliefs, thus people in general are different. Torr instructed to take your message, put it through a prism, and then find answers for each group, be it scientists, government, industry, media, or entrepreneurs. Finally, Act 3 was about being persuasive. You need to tell a story instead of just explaining facts. Torr was adamant that bullets kill; 80% of people are visual learners and thus instead of bullet points we need presentations with story, context, and life. He gave the example of Hans Rosling’s BBC4 talk. Finally he suggested some additional reading: Nancy Baron’s Escape from the Ivory Tower and Resonate (perhaps one of these could be the next book we read for FOSEP’s book club).
Not Science as Usual: Become a AAAS Science and Technology Policy Fellow
Although the title of the next event I attended suggests a focus on the AAAS fellowship, this Career Development Workshop addressed opportunities both in the US and internationally to obtain science and technology policy training. We heard from a recent AAAS Congressional Fellow and representatives from the Canadian Science Policy Center and the US Union of Concerned Scientists. While I was hoping to get more information on the AAAS fellowship, I was encouraged by the wide range of science policy opportunities available both inside and outside of the US.
John P. McGovern Award Lecture in the Behavioral Sciences: Joseph E. LeDoux, The Emotional Brain
After two career development workshops it was time for a lecture pertaining to scientific research. Dr. LeDoux is the Henry and Lucy Moses Professor of Science and University Professor at New York University. He started his talk by explaining that much of what he would present is contained in a Neuron review article due out next month. His talk focused on survival circuits instead of actual emotion because while survival circuits are highly conserved and similarly organized, emotion is a hard to define concept and the circuits involved vary across species. Dr. LeDoux postulated that emotion is what happens when a survival circuit is activated, that feelings result when consciousness witnesses one of these states, and that this is a function of the specific brain an organism has. Dr. LeDoux concluded his presentation by showing fear conditioning data obtained by his laboratory at NYU. He took us through the experiments involved in determining that the central and lateral amygdala are required for fear conditioning, the signal transduction pathways involved, and finally recent studies using optogenetics to further investigate this phenomenon.
Delivering on the Promise of the Human Genome Project
After a short lunch break I next attended the first part of a seminar on unlocking biology’s potential. Although I had to leave early to attend another session I was able to catch Dr. Daniel von Hoff’s lecture titled: The Human Genome Project 11 Years Later: New Medical Treatments for Humanity. Dr. Hoff is an oncologist from the Translational Genomics Research Institute. He spoke about the 7th vital sign of oncology, the context of vulnerability of a tumor cell. He gave examples of phase one clinical trials conducted on patients who had exhausted all other treatment options and had 8-12 weeks to live. Each patient had his or her whole genome sequenced and from that data novel drug targets for each patient were found. Although not successful for most patients, Dr. Hoff showed remarkable examples of rapid remission following treatment with drugs used to target gene mutations found by the genome wide screens. He did stress that although promising, much work is still left; currently only simple cancers (cancers arising from only one mutation) are susceptible to this type of treatment approach, subsequent mutations in the tumor cells as a result of the novel drug treatment can develop rendering the tumor again resistant, and the cost of sequencing is still very high and takes too long (6-8 weeks). While his talk focused solely on cancer, I was also curious how the Human Genome Project is being used to research and treat other medical disorders, unfortunately there was no time allotted for questions at the end of Dr. Hoff’s talk.
Bad Presenter Bingo: The Science Communication Game You Don’t Want To Win
The last event I attended before the Plenary Lecture was a very interesting Career Development Workshop by Monica M. Metzler from the Illinois Science Council (ISC). Metzler founded the ISC as a nonprofit with the goal of science outreach and promotion focused on adult audiences. She started with going through Who, Where, Why, How, and What of science presentations. WHO: consider anyone that doesn’t have a Ph.D. in your subject to be a lay audience and remember that not all audiences are the same. WHERE: Science on Tap, Nerd Nights, science cafes, volunteer opportunities. WHY: giving a talk will make you a better scientist, grant writer, fundraiser, and more attractive to potential employers. HOW: be a normal person, just talk, don’t do things that bother you when you watch others present, and start simple. Its ok to “dumb it down” i.e. make your talk accessible and give context. WHAT: your presentation doesn’t have to be about your research, make it interesting and something people will appreciate because the main goal of public outreach is to get people excited and curious about science. Next Metzler gave us handouts of a bingo card where each square contained a bad habit often seen in science presentations, both presentations aimed at other scientists and at the public. Finally, she ended the session by fielding questions. Although I still have much to improve on in my own presentation skills, I was pleased to see that many of the bad habits listed on the bingo card are ones that have previously been address by my instructors at UW.
Feb 07 2012
H5N1 – when do governments step in to limit scientific research?
Back in December of last year news broke that two groups of scientists, one at the Erasmus Medical Center in Rotterdam, the Netherlands and one at the University of Wisconsin, Madison, created a mutation of the H5N1 avian flu virus that could potentially be contagious among humans (click here for one of the initial reports). Based on the reported cases of people infected by the avian flu virus, the mortality rate of the H5N1 virus is estimated to be 60%. This far exceeds that of the ‘Spanish flu’ of 1918 that killed between 50 and 100 million people worldwide. The accuracy of the 60% mortality rate of the avian flu has been debated by scientists, but even if the true mortality rate ends up 10% of the current estimate, H5N1 would be 3 times more fatal than the Spanish virus.
News covering the incident not only centered on the creation of this potentially dangerous strain of the avian flu virus but also on the intervention by the National Science Advisory Board for Biosecurity (NSABB) to ask the journals to put a temporary hold on the publication of the article and a moratorium on related research until scientists and government officials can assess the risk of publishing the findings from the group from Erasmus. This was a rare intervention by the NSABB. When a group from the Mount Sinai School of Medicine in New York published studies on the reconstruction of the Spanish flu virus back in 2005 there was nothing from the NSABB.
So the question still stands: how much of the study will they make public, if any at all?
A Nature news blog post, as well many others, covered a recent debate on Feb. 2 led by the New York Academy of Science on the issue of how much of the paper should be publicly made available. There were proponents on either side of the debate, some calling for complete retraction of the paper, others calling for complete publication of the details. The debate, in my opinion, boiled down to an argument of whether details about the study will inherently harm or benefit society. On one side, one argued that the details from the paper can be used by the evils of the world to create a deadly virus that can potentially be released into the population, killing many, many people. On the other side, one argued that mutations, like those that the scientists induced, happen in nature and a contagious form of the avian flu, like the H5N1 can appear without human involvement. If we want to be prepared for such a time, you need as many researchers studying H5N1 to better understand the virus… There’s a lot of uncertainty and speculation surrounding the issue, and as this article states, there appears to be very little in terms of international guidelines when such a situation crops up.
As a scientist, it’s beat into my head that we need to be transparent with all our methods and conclusions, for the sake of the integrity of science. If we’re asked for the data we used in a study, we make it available so that others can test whether they come to the same conclusions.
But what happens when the knowledge can be potentially harmful to society? What does one do? When there is uncertainty to what the study results mean in terms of our protection or our harm, who is involved in the decision making process?
I can imagine scientists will be necessary to interpret the results in increasingly complex situations, but who else? There will be uncertainties about how the results will be used, so the decision makers (i.e. governmental advisers, journal publishers) will eventually have to decide on a course of action. Are there others who need to be involved?
The NSABB’s statement on its decisions can be found here. And further discussions and opinions can be found on Nature’s news special online.
Next Page »

